JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 9.58% |
| 3 | Consumer Discretionary | 9.07% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5476
Lexeo Therapeutics
LXEO
$397M
| $93.3K | ﹤0.01% |
5,953
+5,841
| +5,215% | +$91.3K |
|
5477
Transcontinental Realty Investors
TCI
$315M
| $92.9K | ﹤0.01% |
2,467
+1,064
| +76% | +$41.3K |
|
|
GOCO
5478
DELISTED
GoHealth
GOCO
| $92.8K | ﹤0.01% |
8,826
+3,774
| +75% | +$46.7K |
|
|
CHMI
5479
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $92.7K | ﹤0.01% |
26,190
+26,116
| +35,292% | +$95.7K |
|
5480
Actinium Pharmaceuticals
ATNM
$32.6M
| $92.3K | ﹤0.01% |
11,784
-6,788
| -37% | -$43.6K |
|
5481
Omeros
OMER
$1.24B
| $91.9K | ﹤0.01% |
26,628
-14,687
| -36% | -$55.8K |
|
5482
DHI Group
DHX
$171M
| $91.4K | ﹤0.01% |
35,855
+7,483
| +26% | +$18.7K |
|
|
GRTS
5483
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $90.9K | ﹤0.01% |
35,368
-27,806
| -44% | -$67.9K |
|
5484
Douglas Elliman
DOUG
$185M
| $90.8K | ﹤0.01% |
57,453
-82,970
| -59% | -$170K |
|
|
BNT
5485
Brookfield Wealth Solutions
BNT
$13B
| $90.7K | ﹤0.01% |
3,257
-244
| -7% | -$6.57K |
|
5486
Monte Rosa Therapeutics
GLUE
$1.32B
| $90.4K | ﹤0.01% |
12,821
-9,215
| -42% | -$54.7K |
|
5487
Ramaco Resources Class B
METCB
$432M
| $90.3K | ﹤0.01% |
7,761
+4,224
| +119% | +$48.5K |
|
5488
Nuveen Municipal Credit Income Fund
NZF
$2.44B
| $90.3K | ﹤0.01% |
+7,374
| New | +$87.9K |
|
5489
Smartbird Inc
BIRD
$30.1M
| $90.2K | ﹤0.01% |
6,494
+349
| +6% | +$6.51K |
|
5490
iShares MSCI Global Gold Miners ETF
RING
$2.46B
| $90K | ﹤0.01% |
3,558
-7,369
| -67% | -$166K |
|
|
RERE
5491
ATRenew
RERE
$1.01B
| $89.8K | ﹤0.01% |
51,015
+6,879
| +16% | +$9.17K |
|
|
AGEN
5492
Agenus
AGEN
$329M
| $89.8K | ﹤0.01% |
7,739
-4,865
| -39% | -$64.5K |
|
5493
BlackRock MuniHoldings Fund
MHD
$607M
| $89.7K | ﹤0.01% |
7,422
-10,392
| -58% | -$124K |
|
5494
Invesco Municipal Opportunity Trust
VMO
$664M
| $89.5K | ﹤0.01% |
9,202
+266
| +3% | +$2.55K |
|
5495
Global X Aging Population ETF
AGNG
$89.5M
| $89.5K | ﹤0.01% |
+2,972
| New | +$86.5K |
|
5496
DNP Select Income Fund
DNP
$4.14B
| $89.4K | ﹤0.01% |
9,859
+2,379
| +32% | +$21K |
|
|
UDEC
5497
Innovator US Equity Ultra Buffer ETF December
UDEC
$250M
| $89.2K | ﹤0.01% |
+2,670
| New | +$87.3K |
|
5498
Invesco Trust Investment Grade Municipals
VGM
$570M
| $89.1K | ﹤0.01% |
+9,034
| New | +$88.7K |
|
5499
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.4B
| $89K | ﹤0.01% |
+8,039
| New | +$88.2K |
|
5500
Trevi Therapeutics
TRVI
$2.63B
| $87.8K | ﹤0.01% |
25,463
-1,520
| -6% | -$3.39K |
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $43.6B of net new capital in Q1 2024, opening 625 new positions and adding to 3,258 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 766 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.